Abstract
Heterogeneity is a major obstacle to the success of CAR-T therapy in treating solid tumors. The complex tumor microenvironment and varying phenotypes of tumor cells might result in antigen escape, drug resistance, and tumor recurrence. To address this issue, we proposed to use lipid-modified fluorescein isothiocyanate (Lip-FITC) as an artificial ligand to normalize the phenotypes of solid tumor cells. In murine cutaneous melanoma and colon adenocarcinoma that prefer to utilize exogenous long-chain fatty acids, we observed much more uptake of Lip-FITC and significantly increased FITC fluorescence on tumor cell membranes than normal cells. This specific exogenous labeling with FITC enhanced the recognition and selectivity of CART cells in solid tumors, bypassing the limitations derived from antigen expression differences in adoptive cell therapies. Lipid metabolism analysis and in vitro experiments demonstrated the sufficient uptake of long-chain fatty acid (LCFAs)-modified Lip-FITC by solid tumor cells, as well as satisfactory ligand assembly on cell membranes. In solid tumor model, the treatment induced the recognition and initiation of CART cells and successfully suppressed tumor progression through T-cell immunity.
Similar content being viewed by others
References
Agarwalla P, Ogunnaike EA, Ahn S, Froehlich KA, Jansson A, Ligler FS, Dotti G, Brudno Y. Nat Biotechnol, 2022, 40: 1250–1258
Maalej KM, Merhi M, Inchakalody VP, Mestiri S, Alam M, Maccalli C, Cherif H, Uddin S, Steinhoff M, Marincola FM, Dermime S. Mol Cancer, 2023, 22: 20
Abreu TR, Fonseca NA, Gonçalves N, Moreira JN. J Control Release, 2020, 319: 246–261
Cheng EL, Cardle II, Kacherovsky N, Bansia H, Wang T, Zhou Y, Raman J, Yen A, Gutierrez D, Salipante SJ, des Georges A, Jensen MC, Pun SH. J Am Chem Soc, 2022, 144: 13851–13864
Gao F, Cheng Q, Liu MD, Rong L, Liu CJ, Zhang XZ. Sci China Chem, 2019, 62: 1230–1244
Hong M, Clubb JD, Chen YY. Cancer Cell, 2020, 38: 473–488
Nie W, Fan W, Jiang A, Wu G, Liu H, Huang LL, Xie HY. Sci China Chem, 2021, 64: 1999–2009
Liu G, Rui W, Zhao X, Lin X. Cell Mol Immunol, 2021, 18: 1085–1095
Chen Q, Hu Q, Dukhovlinova E, Chen G, Ahn S, Wang C, Ogunnaike EA, Ligler FS, Dotti G, Gu Z. Adv Mater, 2019, 31: e1900192
Hong S, Huang QX, Zhong Z, Rong L, Zhang XZ. CCS Chem, 2022, 4: 1770–1787
Zhang AQ, Hostetler A, Chen LE, Mukkamala V, Abraham W, Padilla LT, Wolff AN, Maiorino L, Backlund CM, Aung A, Melo M, Li N, Wu S, Irvine DJ. Nat Biomed Eng, 2023, doi: https://doi.org/10.1038/s41551-023-01048-8
Zhang M, Di Martino JS, Bowman RL, Campbell NR, Baksh SC, Simon-Vermot T, Kim IS, Haldeman P, Mondal C, Yong-Gonzales V, Abu-Akeel M, Merghoub T, Jones DR, Zhu XG, Arora A, Ariyan CE, Birsoy K, Wolchok JD, Panageas KS, Hollmann T, Bravo-Cordero JJ, White RM. Cancer Discov, 2018, 8: 1006–1025
Wen D, Wang J, Van Den Driessche G, Chen Q, Zhang Y, Chen G, Li H, Soto J, Liu M, Ohashi M, Wang Z, Abdou P, Hu Q, Dotti G, Li S, Fourches D, Gu Z. Matter, 2019, 1: 1203–1214
Wang YY, Attané C, Milhas D, Dirat B, Dauvillier S, Guerard A, Gilhodes J, Lazar I, Alet N, Laurent V, Le Gonidec S, Biard D, Hervé C, Bost F, Ren GS, Bono F, Escourrou G, Prentki M, Nieto L, Valet P, Muller C. JCI Insight, 2017, 2: e87489
Kamphorst JJ, Cross JR, Fan J, de Stanchina E, Mathew R, White EP, Thompson CB, Rabinowitz JD. Proc Natl Acad Sci USA, 2013, 110: 8882–8887
Koonen DPY, Glatz JFC, Bonen A, Luiken JJFP. Biochim Biophys Acta, 2005, 1736: 163–180
Liang T, Wen D, Chen G, Chan A, Chen Z, Li H, Wang Z, Han X, Jiang L, Zhu JJ, Gu Z. Adv Mater, 2021, 33: e2100629
Ubellacker JM, Tasdogan A, Ramesh V, Shen B, Mitchell EC, Martin-Sandoval MS, Gu Z, McCormick ML, Durham AB, Spitz DR, Zhao Z, Mathews TP, Morrison SJ. Nature, 2020, 585: 113–118
Olzmann JA, Carvalho P. Nat Rev Mol Cell Biol, 2019, 20: 137–155
Wang J, Hao JW, Wang X, Guo H, Sun HH, Lai XY, Liu LY, Zhu M, Wang HY, Li YF, Yu LY, Xie C, Wang HR, Mo W, Zhou HM, Chen S, Liang G, Zhao TJ. Cell Rep, 2019, 26: 209–221.e5
van Meer G, Voelker DR, Feigenson GW. Nat Rev Mol Cell Biol, 2008, 9: 112–124
Phillips MJ, Voeltz GK. Nat Rev Mol Cell Biol, 2016, 17: 69–82
Wang B, Tontonoz P. Annu Rev Physiol, 2019, 81: 165–188
Zheng Y, Nandakumar KS, Cheng K. J Med Chem, 2021, 64: 9577–9591
Zhang B, Wang Y, Huang S, Sun J, Wang M, Ma W, You Y, Wu L, Hu J, Song W, Liu X, Li S, Chen H, Zhang G, Zhang L, Zhou D, Li L, Zhang X. Cell Chem Biol, 2021, 28: 60–69.e7
Fan JX, Liu XH, Wang XN, Niu MT, Chen QW, Zheng DW, Wei JS, Yang XQ, Zeng X, Zhang XZ. Adv Funct Mater, 2021, 31: 2009744
Hong S, Huang QX, Ji P, Pang X, Sun Y, Cheng SX, Zhang XZ, Chen X. Sci China Chem, 2022, 65: 1994–2004
Bi J, Ichu TA, Zanca C, Yang H, Zhang W, Gu Y, Chowdhry S, Reed A, Ikegami S, Turner KM, Zhang W, Villa GR, Wu S, Quehenberger O, Yong WH, Kornblum HI, Rich JN, Cloughesy TF, Cavenee WK, Furnari FB, Cravatt BF, Mischel PS. Cell Metab, 2019, 30: 525–538.e8
Yin J, Pidgeon C. Tetrahedron Lett, 1997, 38: 5953–5954
Liu M, Xu W, Xu LJ, Zhong GR, Chen SL, Lu WY. Chem, 2005, 16: 1126–1132
Ortiz RA, Flores RVG, García Valdéz AE, Duarte MLB. Prog Org Coat, 2010, 69: 463–469
Zhang D, Liu C, Chen S, Zhang J, Cheng J, Miao M. Prog Org Coat, 2016, 101: 178–185
Zhang QL, Zheng D, Dong X, Pan P, Zeng SM, Gao F, Cheng SX, Zhang XZ. J Am Chem Soc, 2021, 143: 5127–5140
Ma X, Liang X, Li Y, Feng Q, Cheng K, Ma N, Zhu F, Guo X, Yue Y, Liu G, Zhang T, Liang J, Ren L, Zhao X, Nie G. Nat Commun, 2023, 14: 1606
Sockolosky JT, Dougan M, Ingram JR, Ho CCM, Kauke MJ, Almo SC, Ploegh HL, Garcia KC. Proc Natl Acad Sci USA, 2016, 113: E2646–E2654
Fan JX, Peng MY, Wang H, Zheng HR, Liu ZL, Li CX, Wang XN, Liu XH, Cheng SX, Zhang XZ. Adv Mater, 2019, 31: e1808278
Jiang H, Guo Y, Yu Z, Hu P, Shi J. Natl Sci Rev, 2022, 9: nwac169
Chen WH, Chen QW, Chen Q, Cui C, Duan S, Kang Y, Liu Y, Liu Y, Muhammad W, Shao S, Tang C, Wang J, Wang L, Xiong MH, Yin L, Zhang K, Zhang Z, Zhen X, Feng J, Gao C, Gu Z, He C, Ji J, Jiang X, Liu W, Liu Z, Peng H, Shen Y, Shi L, Sun X, Wang H, Wang J, Xiao H, Xu FJ, Zhong Z, Zhang XZ, Chen X. Sci China Chem, 2022, 65: 1010–1075
Wu Y, Wen H, Bernstein ZJ, Hainline KM, Blakney TS, Congdon KL, Snyder DJ, Sampson JH, Sanchez-Perez L, Collier JH. Sci Adv, 2022, 8: eabm7833
Acknowledgements This work was supported by the National Natural Science Foundation of China (52103319, 22135005, 51988102). All of the animal experiments were conducted under protocols approved by the Institutional Animal Care and Use Committee (IACUC) of the Animal Experiment Center of Wuhan University (Wuhan, China).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest The authors declare no conflict of interest.
Additional information
Supporting information The supporting information is available online at http://chem.scichina.com and http://link.springer.com/journal/11426. The supporting materials are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains entirely with the authors.
Rights and permissions
About this article
Cite this article
Fan, JX., Hu, ZB., Gu, HY. et al. Tumor cell membrane remodeling with universal ligand for CAR-T cells to inhibit solid tumors. Sci. China Chem. 66, 3223–3231 (2023). https://doi.org/10.1007/s11426-023-1796-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-023-1796-0